Jun 12 |
Presenting on the Emerging Growth Conference 72 Day 2 on June 13 Register Now
|
Jun 11 |
SeaStar Medical’s Selective Cytopheretic Device Featured in Two Presentations at the 42nd Vicenza Course AKI-CRT-ECOS and Critical Care Nephrology
|
Jun 11 |
Presenting on the Emerging Growth Conference 72 Day 1 on June 12 Register Now
|
Jun 7 |
Article in Nature Scientific Reports Describes Mechanism of Action of SeaStar Medical’s Selective Cytopheretic Device in the Immunomodulation of Excessive Inflammation
|
Jun 6 |
SeaStar Medical to Present at the Virtual Emerging Growth Conference on June 12, 2024
|
Jun 6 |
SeaStar Medical to conduct a reverse stock split
|
Jun 6 |
SeaStar Medical Announces 25-for-1 Reverse Stock Split
|
May 24 |
Seastar touts positive case studies for selective cytopheretic device
|
May 22 |
Manuscript Published on Multiorgan Failure Patients Treated with SeaStar Medical’s Selective Cytopheretic Device Who Achieved Transplant Eligibility
|
May 15 |
SeaStar Medical Holding GAAP EPS of -$0.19 misses by $0.05
|